97 related articles for article (PubMed ID: 25574519)
1. Infrared imaging of primary melanomas reveals hints of regional and distant metastases.
Wald N; Goormaghtigh E
Analyst; 2015 Apr; 140(7):2144-55. PubMed ID: 25574519
[TBL] [Abstract][Full Text] [Related]
2. Identification of melanoma cells and lymphocyte subpopulations in lymph node metastases by FTIR imaging histopathology.
Wald N; Bordry N; Foukas PG; Speiser DE; Goormaghtigh E
Biochim Biophys Acta; 2016 Feb; 1862(2):202-12. PubMed ID: 26612718
[TBL] [Abstract][Full Text] [Related]
3. Differential expression of vascular endothelial growth factor-A isoforms at different stages of melanoma progression.
Gorski DH; Leal AD; Goydos JS
J Am Coll Surg; 2003 Sep; 197(3):408-18. PubMed ID: 12946796
[TBL] [Abstract][Full Text] [Related]
4. Vascular endothelial growth factor C mRNA expression correlates with stage of progression in patients with melanoma.
Goydos JS; Gorski DH
Clin Cancer Res; 2003 Dec; 9(16 Pt 1):5962-7. PubMed ID: 14676121
[TBL] [Abstract][Full Text] [Related]
5. RANK is expressed in metastatic melanoma and highly upregulated on melanoma-initiating cells.
Kupas V; Weishaupt C; Siepmann D; Kaserer ML; Eickelmann M; Metze D; Luger TA; Beissert S; Loser K
J Invest Dermatol; 2011 Apr; 131(4):944-55. PubMed ID: 21270824
[TBL] [Abstract][Full Text] [Related]
6. An infrared spectral signature of human lymphocyte subpopulations from peripheral blood.
Wald N; Legat A; Meyer C; Speiser DE; Goormaghtigh E
Analyst; 2015 Apr; 140(7):2257-65. PubMed ID: 25553786
[TBL] [Abstract][Full Text] [Related]
7. Infrared spectra of primary melanomas can predict response to chemotherapy: The example of dacarbazine.
Wald N; Le Corre Y; Martin L; Mathieu V; Goormaghtigh E
Biochim Biophys Acta; 2016 Feb; 1862(2):174-81. PubMed ID: 26577766
[TBL] [Abstract][Full Text] [Related]
8. Biologic and prognostic significance of dermal Ki67 expression, mitoses, and tumorigenicity in thin invasive cutaneous melanoma.
Gimotty PA; Van Belle P; Elder DE; Murry T; Montone KT; Xu X; Hotz S; Raines S; Ming ME; Wahl P; Guerry D
J Clin Oncol; 2005 Nov; 23(31):8048-56. PubMed ID: 16258103
[TBL] [Abstract][Full Text] [Related]
9. Breast cancer and melanoma cell line identification by FTIR imaging after formalin-fixation and paraffin-embedding.
Verdonck M; Wald N; Janssis J; Yan P; Meyer C; Legat A; Speiser DE; Desmedt C; Larsimont D; Sotiriou C; Goormaghtigh E
Analyst; 2013 Jul; 138(14):4083-91. PubMed ID: 23689823
[TBL] [Abstract][Full Text] [Related]
10. Characterization of human breast cancer tissues by infrared imaging.
Verdonck M; Denayer A; Delvaux B; Garaud S; De Wind R; Desmedt C; Sotiriou C; Willard-Gallo K; Goormaghtigh E
Analyst; 2016 Jan; 141(2):606-19. PubMed ID: 26535413
[TBL] [Abstract][Full Text] [Related]
11. Detection of melanoma cells in the blood of melanoma patients by melanoma-inhibitory activity (MIA) reverse transcription-PCR.
Mühlbauer M; Langenbach N; Stolz W; Hein R; Landthaler M; Buettner R; Bosserhoff AK
Clin Cancer Res; 1999 May; 5(5):1099-105. PubMed ID: 10353744
[TBL] [Abstract][Full Text] [Related]
12. Neuropeptide Y expression in cutaneous melanoma.
Gilaberte Y; Roca MJ; Garcia-Prats MD; Coscojuela C; Arbues MD; Vera-Alvarez JJ
J Am Acad Dermatol; 2012 Jun; 66(6):e201-8. PubMed ID: 21620518
[TBL] [Abstract][Full Text] [Related]
13. Evidence and interdisciplinary consense-based German guidelines: diagnosis and surveillance of melanoma.
Garbe C; Hauschild A; Volkenandt M; Schadendorf D; Stolz W; Reinhold U; Kortmann RD; Kettelhack C; Frerich B; Keilholz U; Dummer R; Sebastian G; Tilgen W; Schuler G; Mackensen A; Kaufmann R
Melanoma Res; 2007 Dec; 17(6):393-9. PubMed ID: 17992123
[TBL] [Abstract][Full Text] [Related]
14. Minichromosome maintenance protein expression in benign nevi, dysplastic nevi, melanoma, and cutaneous melanoma metastases.
Boyd AS; Shakhtour B; Shyr Y
J Am Acad Dermatol; 2008 May; 58(5):750-4. PubMed ID: 18249467
[TBL] [Abstract][Full Text] [Related]
15. Fourier transform infrared imaging as a method for detection of HLA class I expression in melanoma without the use of antibody.
Chew SF; Wood BR; Kanaan C; Browning J; MacGregor D; Davis ID; Cebon J; Tait BD; McNaughton D
Tissue Antigens; 2007 Apr; 69 Suppl 1():252-8. PubMed ID: 17445214
[TBL] [Abstract][Full Text] [Related]
16. Immunoreactivity with the anti-MAGE antibody 57B in malignant melanoma: frequency of expression and correlation with prognostic parameters.
Busam KJ; Iversen K; Berwick M; Spagnoli GC; Old LJ; Jungbluth AA
Mod Pathol; 2000 Apr; 13(4):459-65. PubMed ID: 10786815
[TBL] [Abstract][Full Text] [Related]
17. Discrimination of melanoma cell lines with Fourier Transform Infrared (FTIR) spectroscopy.
Shakya BR; Teppo HR; Rieppo L
Spectrochim Acta A Mol Biomol Spectrosc; 2021 Jun; 254():119665. PubMed ID: 33744696
[TBL] [Abstract][Full Text] [Related]
18. Nuclear morphometry of MIB-1 positive and negative tumor cells in primary and metastatic malignant melanoma of the skin.
Karbowniczek M; Chosia M; Domagała W
Pol J Pathol; 1999; 50(4):235-41. PubMed ID: 10721263
[TBL] [Abstract][Full Text] [Related]
19. Gene expression profiling of human angiotropic primary melanoma: selection of 15 differentially expressed genes potentially involved in extravascular migratory metastasis.
Lugassy C; Lazar V; Dessen P; van den Oord JJ; Winnepenninckx V; Spatz A; Bagot M; Bensussan A; Janin A; Eggermont AM; Barnhill RL
Eur J Cancer; 2011 May; 47(8):1267-75. PubMed ID: 21334873
[TBL] [Abstract][Full Text] [Related]
20. Metastatic lesions with and without interleukin-18-dependent genes in advanced-stage melanoma patients.
Crende O; Sabatino M; Valcárcel M; Carrascal T; Riestra P; López-Guerrero JA; Nagore E; Mandruzzato S; Wang E; Marincola FM; Vidal-Vanaclocha F
Am J Pathol; 2013 Jul; 183(1):69-82. PubMed ID: 23707237
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
